Track the 이엔셀 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 이엔셀 has published 33 reports. Market capitalisation: €60.6bn. The latest transaction was reported on 25 June 2026 (Purchase). Among the most active insiders: 장종욱. All data is free.
33
Insider Decl.
n/a
Thresholds
n/a
27 ops.
Buy Volume
€1m
5 ops.
Sell Volume
22Σ signal
Buys n/a€1m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 27,682 of 27,906 companies
6.6
score / 100
Value
9
Quality
4
FCF yld-22%
Earn yld-27%
EV/EBITDA·
ROE-42%
Gross mgn-46%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.